Multi-Lingual and Compact: Schreiner MediPharm Supplies Booklet-Label for Clinical Trial at Sanofi
Oberschleissheim, May 7, 2020 – Schreiner MediPharm has developed a compact Booklet-Label for a needle protection system used in an international phase III clinical trial conducted by pharmaceutical corporation Sanofi. On more than 30 pages, the extensive yet small booklet contains all the required product information in more than 20 languages.
Accuracy, safety, efficiency and speed are essential to the successful performance of clinical trials.